1 Min Read
April 26 (Reuters) - Pharmathene Inc:
* Pharmathene and Altimmune announce combined company approved for trading on NASDAQ global market Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.